ACT NoW: Assessing the Effectiveness of Communication Therapy in the North West

NACompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

July 31, 2010

Study Completion Date

October 31, 2010

Conditions
Stroke
Interventions
OTHER

Speech and Language Therapy (SLT)

Participants randomised into the treatment arm will receive early SLT of up to three sessions per week for a maximum duration of 16 weeks. The SLT intervention has been developed by a team of expert Speech and Language Therapists according to 'Best Practice Standards'. The intervention procedure is manualised to allow replicability by other Speech Therapy Departments if it is shown to be effective.

OTHER

Attention Control

Those in the attention control arm of the trial will receive similar levels of contact as those in the SLT arm. However contact will be with an ACT NoW Visitor who has no specific knowledge about communication therapy. They will provide empathy and spend time with the patient, without any input from Speech and Language Therapists.

Trial Locations (1)

M13 9PL

The University of Manchester, Manchester

All Listed Sponsors
lead

University of Manchester

OTHER

NCT00831740 - ACT NoW: Assessing the Effectiveness of Communication Therapy in the North West | Biotech Hunter | Biotech Hunter